Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
Quick Stats
Jan 30, 202649.0
AI Score
HOLD0.05
Volume Ratio
Next Earnings
11
+ve Days (30d)
19
-ve Days (30d)
JAGX Stock Summary
Last updated Jan 30, 2026
JAGX is currently trading at $0.6746, positioned below its 200-day moving average of $2.82, suggesting bearish momentum. The stock has a 52-week range of $0.6401 to $25.75.
Technical Analysis: The 50-day moving average stands at $1.06, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 40.373, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.185, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates JAGX at 49.0/100 with a HOLD recommendation.
JAGX (Jaguar Health, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 40.373 |
| CMF (20) | -0.185 |
| ROC (10) | -11.759 |
| ADX (14) | 23.789 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.127 |
| AROONOSC (14) | 21.429 |
| WILLAMS %R (14) | -97.195 |
| MFI (14) | 85.186 |
JAGX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
JAGX Price vs Max Options Open Interest
JAGX Max Change In Options Open Interest
JAGX Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAGX Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAGX Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
JAGX Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Jaguar Health, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
JAGX Moving Averages Analysis
JAGX (Jaguar Health, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 0.81 |
| 20 | 0.88 |
| 30 | 0.95 |
| 50 | 1.06 |
| 100 | 1.53 |
| 200 | 2.82 |
JAGX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.8 million |
| Earnings/Share ($) | -2.58 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -23.81 |
| EPS Estimate Next Year ($) | -5.68 |
| WallStreet Target Price ($) | 25.5 |
| Most Recent Quarter |